|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 14/745 | |||
| C07K 16/36 |
| (11) | Patento numeris | 2297207 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09766879.2 |
| Europos patento paraiškos padavimo data | 2009-06-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/NL2009/050361 |
| Data | 2009-06-19 |
| (87) | Numeris | WO 2009/154461 |
| Data | 2009-12-23 |
| (30) | Numeris | Data | Šalis |
| 73882 P | 2008-06-19 | US |
| (72) |
Hack, Erik, NL
|
| (73) |
Prothix BV,
Warmonderweg 23, 2334 AB Leiden,
NL
|
| (54) | USE OF ANTI-FACTOR XI ANTIBODIES FOR PREVENTION OR TREATMENT OF THROMBUS FORMATION |
| USE OF ANTI-FACTOR XI ANTIBODIES FOR PREVENTION OR TREATMENT OF THROMBUS FORMATION |